February 25, 2021 -- The Hennessy Group, an executive search firm specializing in life sciences, announces the recent placement of Scott Waldman as Senior Vice President, Corporate Development at Albany Molecular Research, Inc. (AMRI), a leading contract research development and manufacturing company. AMRI is a portfolio company of The Carlyle Group and CTGR.
Waldman will drive AMRI’s key growth initiatives globally, including mergers and acquisitions, while serving as a member of the executive committee. He brings over 25 years of experience to the role, in corporate development and as a general counsel and corporate lawyer, with more than 15 years focused on the pharmaceutical and pharmaceutical services industries. Most recently, he was an advisor to private equity firms and select pharmaceutical industry clients. Previously, Waldman worked in a number of executive roles at Lonza Group, including serving as Chief Strategy Officer, where he led Lonza’s M&A activities.
"The Hennessy Group is proud to contribute to AMRI’s growth strategy by placing Scott in this critical function. Scott comes from the top of the corporate development talent market in CDMO. His expertise, coupled with AMRI’s focus on growth and global expansion, makes this a dynamic pairing that we are proud to have been a part of. We have great expectations for both Scott and AMRI and look forward to watching their future successes,” said Robert D. Hennessy, CEO of The Hennessy Group.
Known for its fast executive search process, The Hennessy Group delivered a full candidate slate to AMRI in under 30 days and closed the search project in 65 days.
Focused on speed, candidate care and development, guaranty of fit, and high placement stick rate, The Hennessy Group has been placing leaders in the life sciences industry for over 20 years. Learn more at thehennessygroup.com or contact us at [email protected] to discuss your company’s executive search needs.
